Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | 94 164 | déclaré | 31 janv. 2026 | tx 21+1 086 178−226 164 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 31 janv. 2026 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 11 570 | 4.24 USD | |
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 42 083 | — | |
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 8 750 | 0.00 USD | deriv |
| 31 janv. 2026 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 119 520 | 0.00 USD | deriv |
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 33 333 | 0.00 USD | deriv |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 8 750 | — | |
| 31 janv. 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 33 333 | — | |
| 31 janv. 2025 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 11 517 | 3.06 USD | |
| 31 janv. 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 33 333 | 0.00 USD | deriv |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 132 800 | 0.00 USD | deriv |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 8 750 | 0.00 USD | deriv |
| 01 févr. 2024 | SALE | Atea Pharmaceuticals, Inc. | 11 819 | 3.84 USD | |
| 31 janv. 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 33 334 | — | |
| 31 janv. 2024 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 132 800 | 0.00 USD | deriv |
| 31 janv. 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 33 334 | 0.00 USD | deriv |
| 31 janv. 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 140 000 | 0.00 USD | deriv |
| 31 janv. 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 100 000 | 0.00 USD | deriv |
| 31 janv. 2022 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 135 000 | 0.00 USD | deriv |
| 29 janv. 2021 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 117 300 | 0.00 USD | deriv |
| 03 nov. 2020 | CONVERSION | Atea Pharmaceuticals, Inc. | 82 508 | — | |
| 03 nov. 2020 | CONVERSION | Atea Pharmaceuticals, Inc. | 82 508 | — | deriv |